SCHEMBL16009409

SCHEMBL16009409

Cc1noc(C)c1CCN1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 1/20 0.53
STAT3 P40763 2/20 0.47
GPR119 Q8TDV5 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.40
USP2 O75604 1/20 0.40
ACKR3 P25106 2/20 0.40
AR P10275 3/20 0.40
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
MAPT P10636 2/20 0.39
TSHR P16473 2/20 0.39
HTT P42858 2/20 0.39
TERT O14746 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL208417 0.88 TLR8 (0.47) TLR8STAT3GPR119SMN1; SMN2USP2
SCHEMBL14678562 0.77 SMN1; SMN2 (0.40) STAT3SMN1; SMN2ARMAPTTSHR
SCHEMBL14678033 0.76 AR (0.40) SMN1; SMN2ARLMNA
SCHEMBL16009227 0.76 BRD4 (0.40) STAT3SMN1; SMN2ARMAPTTSHR
SCHEMBL20873847 0.75 USP2 (0.53) TLR8SMN1; SMN2USP2ACKR3CHRM2
SCHEMBL8242595 0.75 USP2 (0.61) TLR8SMN1; SMN2USP2ACKR3CHRM2
SCHEMBL38654186 0.72 GPR119 (0.54) GPR119SMN1; SMN2USP2MAPTHTT
SCHEMBL15353080 0.71 SMN1; SMN2 (0.72) SMN1; SMN2USP2ACKR3CHRM2CHRM4
SCHEMBL17782085 0.71 HPGD (0.49) TLR8SMN1; SMN2USP2ACKR3CHRM2
SCHEMBL4832556 0.71 GPR119 (0.57) GPR119ACKR3CHRM2CHRM4CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256740-A1 COMPOUNDS AND METHODS TEMPERO PHARMACEUTICALS, INC. (US) 2014-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256740-A1 COMPOUNDS AND METHODS RORC, RORB, RORA TLR8 556/4885STAT3 253/4885GPR119 70/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.